Agilent Technologies, Inc. (A)
172.97
-2.58
(-1.47%)
USD |
NYSE |
Oct 16, 16:00
172.96
-0.01
(-0.01%)
After-Hours: 20:00
Agilent Technologies Cash from Investing (Quarterly) : -1.032B for July 31, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | -1.032B |
| April 30, 2026 | -77.00M |
| January 31, 2026 | -93.00M |
| October 31, 2025 | -90.00M |
| July 31, 2025 | -96.00M |
| April 30, 2025 | -114.00M |
| January 31, 2025 | -94.00M |
| October 31, 2024 | -954.00M |
| July 31, 2024 | -100.00M |
| April 30, 2024 | -109.00M |
| January 31, 2024 | -95.00M |
| October 31, 2023 | -40.00M |
| July 31, 2023 | -89.00M |
| April 30, 2023 | -77.00M |
| January 31, 2023 | -104.00M |
| October 31, 2022 | -110.00M |
| July 31, 2022 | -73.00M |
| April 30, 2022 | -76.00M |
| January 31, 2022 | -79.00M |
| October 31, 2021 | -59.00M |
| July 31, 2021 | -61.00M |
| April 30, 2021 | -587.00M |
| January 31, 2021 | -42.00M |
| October 31, 2020 | -27.00M |
| July 31, 2020 | -32.00M |
| Date | Value |
|---|---|
| April 30, 2020 | -53.00M |
| January 31, 2020 | -35.00M |
| October 31, 2019 | -1.193B |
| July 31, 2019 | -55.00M |
| April 30, 2019 | -56.00M |
| January 31, 2019 | -290.00M |
| October 31, 2018 | -114.00M |
| July 31, 2018 | -473.00M |
| April 30, 2018 | -51.00M |
| January 31, 2018 | -67.00M |
| October 31, 2017 | -59.00M |
| July 31, 2017 | -101.00M |
| April 30, 2017 | -43.00M |
| January 31, 2017 | -101.00M |
| October 31, 2016 | -78.00M |
| July 31, 2016 | -24.00M |
| April 30, 2016 | -108.00M |
| January 31, 2016 | -273.00M |
| October 31, 2015 | -275.00M |
| July 31, 2015 | -87.00M |
| April 30, 2015 | 803.00M |
| January 31, 2015 | -31.00M |
| October 31, 2014 | -58.00M |
| July 31, 2014 | -70.00M |
| April 30, 2014 | -55.00M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Thermo Fisher Scientific, Inc. | 164.00M |
| Danaher Corp. | -10.15B |
| Illumina, Inc. | -122.00M |
| Bio-Rad Laboratories, Inc. | -66.70M |
| Revvity, Inc. | -3.505M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 519.00M |
| Cash from Financing (Quarterly) | 471.00M |
| Free Cash Flow | 1.267B |
| Free Cash Flow Per Share (Quarterly) | 1.551 |
| Free Cash Flow to Equity (Quarterly) | -155.00M |
| Free Cash Flow to Firm (Quarterly) | 462.64M |
| Free Cash Flow Yield | 2.58% |